TriCipher Joins SAFE BioPharma Association Vendor Partner Program
TriCipher has joined the SAFE (Signatures and Authentication for Everyone) BioPharma Association Vendor Partner Program, pledging to promote the adoption of the SAFE standards through the company's user and transaction authentication solutions. SAFE-approved credentials will seamlessly operate on TriCipher Armored Credential System, the company's authentication platform leveraging a variety of multi-factor credentials.
The industry group gives TriCipher access to forward-thinking corporate users of digital information processing, such as Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. By agreeing to credentialing standards, these companies reduce the cost and time for pharmaceutical companies to advance drug development and deploy new business processes.
SAFE provides the industry's legal foundation for digital signatures and user authentication across pharmaceutical companies. Its standards are legally enforceable because they ensure user authentication, digital document integrity and auditable non-repudiation of users' actions.
write your comments about the article :: © 2007 Computing News :: home page